The treatment of a chronic organic mental disorder with dextromethorphan in a man with severe mental retardation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1638308.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Response to dextromethorphan (15 mg b.i.d.), an antitussive agent not usually considered to have psychotropic properties, was seen in a 25-year-old man with severe developmental disabilities, congenital rubella, and an organic mental disorder. Dextromethorphan affects CNS serotonergic systems, and this was the probable therapeutic mechanism. This and other published cases suggest the existence of a distinct organic mental syndrome in developmentally disabled persons which responds to drugs that increase indoleaminergic activity.
Medical subject headings
- Dextromethorphan
- Intellectual Disability
- Neurocognitive Disorders